The DeepView System demonstrated a statistically significant improvement in identifying non-healing tissue compared to burn physician. Spectral AI plans to submit these results to the FDA as part ...

Spectral AI has completed the data analysis for its pivotal Burn Study, in the US, designed for the validation of its DeepView System's artificial intelligence (AI)-powered algorithm for burn ...

Spectral AI's DeepView System excels over physicians in identifying non-healing burn tissue, aiming for FDA clearance by mid-2025. Spectral AI has announced positive results from its Burn ...

DALLAS, March 17, 2025 (GLOBE NEWSWIRE) -- Spectral AI (NASDAQ: MDAI) (“Spectral AI” or the “Company”), developer of the AI-driven DeepView ® System, that uses multi-spectral imaging and ...

Spectral AI, a Dallas-based company specializing in predictive AI for medical diagnostics, has announced the installation of three DeepView® System devices in Australia, following the Australian ...

DeepView ® System outperforms burn physicians in identifying non-healing tissue Landmark Burn Validation Study, one of the largest in U.S. history, confirms DeepView’s performance Spectral AI ...